Association of 12 serum biochemical markers of angiogenesis, tumour invasion and bone turnover with bone metastases from breast cancer: a crossectional and longitudinal evaluation
Open Access
- 1 August 2006
- journal article
- research article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 95 (4), 506-514
- https://doi.org/10.1038/sj.bjc.6603285
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Metastasis gets site specificCancer Cell, 2005
- The multifunctional role of the immunohistochemical expression of MMP‐7 in invasive breast cancerAPMIS, 2005
- Prognostic value of matrix metalloproteinases (MMP-2 and MMP-9) in patients with lymph node-negative breast carcinomaBreast Cancer Research and Treatment, 2004
- A High Serum Matrix Metalloproteinase-2 Level Is Associated with an Adverse Prognosis in Node-Positive Breast CarcinomaClinical Cancer Research, 2004
- Markers of Bone Remodeling in Metastatic Bone DiseaseJournal of Clinical Endocrinology & Metabolism, 2003
- The Type I Collagen Fragments ICTP and CTX Reveal Distinct Enzymatic Pathways of Bone Collagen DegradationJournal of Bone and Mineral Research, 2003
- Elevated plasma levels of transforming growth factor-β1 (TGF-β1) in patients with advanced breast cancer: association with disease progressionEuropean Journal Of Cancer, 2003
- Interactions between Cancer and Bone Marrow Cells Induce Osteoclast Differentiation Factor Expression and Osteoclast-like Cell Formation in VitroBiochemical and Biophysical Research Communications, 2000
- Immunological Characterization of Circulating Osteoprotegerin/Osteoclastogenesis Inhibitory Factor: Increased Serum Concentrations in Postmenopausal Women with OsteoporosisJournal of Bone and Mineral Research, 1999
- Transforming growth factors type β1 and β2 are equipotent growth inhibitors of human breast cancer cell linesJournal of Cellular Physiology, 1989